Skip to main content

Table 3 Changes in the scores in the simulator sickness questionnaire

From: Fully immersive virtual reality exergames with dual-task components for patients with Parkinson’s disease: a feasibility study

No

Age

Sex

DD (mo)

Before intervention

After 1st session

After intervention

N

O

D

Total

N

O

D

Total

N

O

D

Total

1

78

F

116

28.62

22.74

13.92

26.18

38.16

15.16

0

22.44

19.08

22.74

41.76

29.92

2

78

F

71

38.16

7.58

13.92

22.44

19.08

7.58

0

11.22

9.54

7.58

27.84

14.96

3

75

F

62

19.08

37.90

27.84

33.66

0

7.58

27.84

14.96

19.08

45.48

41.76

41.14

4

72

F

57

28.62

83.38

55.68

67.32

0

7.58

27.84

18.70

28.62

68.22

69.60

59.84

5

69

F

183

9.54

15.16

0

11.22

28.62

0

0

11.22

47.70

68.22

69.60

67.32

6

83

M

196

47.70

60.64

55.68

63.58

9.54

45.48

41.76

41.14

9.54

7.58

0

7.48

7

78

F

185

28.62

22.74

27.84

29.92

38.16

7.58

0

11.22

38.16

68.22

41.76

59.84

8

60

M

107

0

0

0

0

0

0

0

0

0

0

0

0

9

78

F

59

0

0

0

0

0

0

0

0

0

0

0

0

10

68

F

102

38.16

60.64

0

44.88

0

0

0

0

9.54

0

13.92

7.48

11

74

F

318

76.32

60.64

41.76

71.06

19.08

37.9

69.6

48.62

47.70

60.64

55.68

59.84

12

73

M

102

19.08

22.74

13.92

22.44

9.54

22.74

13.92

18.70

57.24

60.64

55.68

67.32

Median (IQR)

28.62 (21.47)

22.74 (47.38)

13.92 (31.32)

28.05 (29.92)

9.54 (21.47)

7.58 (17.06)

0 (27.84)

13.09 (11.22)

19.08 (31.01)

34.11 (56.85)

41.76 (45.24)

35.53 (52.36)

P

0.058

0.011*

0.238

0.008*

0.723

0.933

0.054

0.959

  1. DD, disease duration; IQR, interquartile range; N, nausea; O, oculomotor; D, disorientation
  2. *p < 0.05 by Wilcoxon signed-rank test (compared with pre-intervention score)